Regencell Bioscience Holdings Limited Detailed Financials

Full historical quarterly statements

Metric2025-12-312025-06-302024-12-292024-06-302023-12-302023-06-302022-12-302022-06-30
Total Revenue0000000-2.34B
Cost of Goods Sold41K0000770K0604K
Gross Profit-41K0000-770K0-2.34B
R&D Expenses416K441K507K290.742242.375232K1.4M1.4M
Operating Expenses5.3M1.8M2.0M1K1K2.1M3.4M3.4M
Operating Income-5.3M-1.8M-2.0M-1K-1K-2.8M-3.4M-4.0M
Other Income / Gains22K62K124K123.771-1.1M-1.3M-1.5M-3.9M
Net Income-5.3M-1.7M-1.9M-1K-1K-2.6M-3.2M-3.9M
EPS (Diluted)-0.011-0.004-0.140-0.00-0.005-0.007-0.008
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000001.00
General And Administrative Expenses00732K743.475865.0222K2K2K
Selling And Marketing Expenses004K14.18348.531164.5798.09417.228
Selling General And Administrative Expenses4.9M1.4M1.5M977.561913.5531.8M2.1M2.0M
Other Expenses000-55.8680.00000
Cost And Expenses5.3M1.8M2.0M1K1K2.8M3.4M4.0M
Interest Income00000000
Interest Expense00000000
Depreciation And Amortization41K076K73.28473.284770K75.074604K
Ebitda-5.3M-1.7M-1.8M-1K-1.2M-3.4M-5.0M-5.3M
Ebitdaratio00000000.002
Operating Income Ratio00000000.002
Income Before Tax-5.3M-1.7M-1.9M-1K-1K-2.7M-3.3M-3.9M
Income Before Tax Ratio00000000.002
Income Tax Expense0000-59.636-51.669-43.931-81.246
Net Income Ratio00000000.002
Epsdiluted-0.011-0.004-0.140-0.00-0.005-0.007-0.008
Weighted Average Shs Out494.5M494.5M13.0M494.5M494.5M494.5M494.5M494.5M
Weighted Average Shs Out Dil494.5M494.5M13.0M494.5M494.5M494.5M494.5M494.5M